
Zimmer Biomet ownership: holders and insider trading
$103.21−1.29%Close 13 Nov 2026
As filed, its directors and officers own 0.7% of the shares (proxy statement, 1 Jan 2026); 902 institutional managers reported holding 99.3% at 30 Jun 2026. Over the last twelve months, insiders sold $1.58M of shares on the open market, and bought none.
From the company's proxy statement, each holder's latest Schedule 13D or 13G, the institutional managers' quarterly 13F reports and the insiders' Form 4 filings. A percentage is shown as filed; one marked * is worked out here from the shares outstanding.
Largest holders
| Holder | Type | Shares | Of the company | Source | As of |
|---|
| Dodge & Cox | Holder | 24.1M | 12.75%* | Form 13F | 30 Jun 2026 |
|---|
| The Vanguard Group | Holder | 23.1M | 12.21%* | Form 13F | 30 Jun 2026 |
|---|
| BlackRock | Institution | 15.6M | 8.25%* | Form 13F | 30 Jun 2026 |
|---|
| Vanguard Capital Management | Holder | 14.8M | 7.54% | Schedule 13G | 31 Mar 2026 |
|---|
| Harris Associates L P | Institution | 12.7M | 6.73%* | Form 13F | 30 Jun 2026 |
|---|
| Capital International Investors | Holder | 12.4M | 6.4% | Schedule 13G | 30 Jun 2026 |
|---|
| Capital Group | Institution | 12.2M | 6.45%* | Form 13F | 30 Jun 2026 |
|---|
| State Street | Institution | 8.9M | 4.69%* | Form 13F | 30 Jun 2026 |
|---|
| Geode Capital Management | Institution | 5.3M | 2.83%* | Form 13F | 30 Jun 2026 |
|---|
| T. Rowe Price | Institution | 4.8M | 2.53%* | Form 13F | 30 Jun 2026 |
|---|
| UBS | Institution | 4.2M | 2.23%* | Form 13F | 30 Jun 2026 |
|---|
| Invesco | Institution | 4.0M | 2.10%* | Form 13F | 30 Jun 2026 |
|---|
| Primecap Management Co | Institution | 3.8M | 2.02%* | Form 13F | 30 Jun 2026 |
|---|
| Van Eck Associates Corp | Institution | 3.5M | 1.85%* | Form 13F | 30 Jun 2026 |
|---|
| Citadel | Institution | 3.5M | 1.84%* | Form 13F | 30 Jun 2026 |
|---|
| Hotchkis & Wiley Capital Management LLC | Institution | 2.8M | 1.46%* | Form 13F | 30 Jun 2026 |
|---|
| American Century Companies Inc | Institution | 2.7M | 1.45%* | Form 13F | 30 Jun 2026 |
|---|
| Morgan Stanley | Institution | 2.6M | 1.37%* | Form 13F | 30 Jun 2026 |
|---|
| Bank of America | Institution | 2.2M | 1.15%* | Form 13F | 30 Jun 2026 |
|---|
| Northern Trust | Institution | 2.0M | 1.04%* | Form 13F | 30 Jun 2026 |
|---|
Insider transactions latest 25
| Insider | Date | Transaction | Shares | Price | Value |
|---|
| Campbell Gary Craig · President, Americas | 1 Oct 2026 | Option exercise | +2.4K | — | — |
|---|
| Campbell Gary Craig · President, Americas | 1 Oct 2026 | Shares withheld for tax | −932 | $88.42 | $82.41K |
|---|
| Campbell Gary Craig · President, Americas | 1 Oct 2026 | Option exercise | +1.2K | — | — |
|---|
| Campbell Gary Craig · President, Americas | 1 Oct 2026 | Shares withheld for tax | −480 | $88.42 | $42.44K |
|---|
| Thornal Kevin R · Grp Pres-Global Business | 11 Sep 2026 | Open-market sale | −5.7K | $92.95 | $529.0K |
|---|
| Phipps Chad F · See remarks below. | 4 Sep 2026 | Open-market sale | −3.0K | $98.35 | $295.1K |
|---|
| Thornal Kevin R · Grp Pres-Global Business | 1 Aug 2026 | Option exercise | +10.0K | — | — |
|---|
| Thornal Kevin R · Grp Pres-Global Business | 1 Aug 2026 | Shares withheld for tax | −4.3K | $92.68 | $395.4K |
|---|
| Yi Sang · Group President, Asia Pacific | 29 May 2026 | Open-market sale | −4.2K | $82.64 | $347.1K |
|---|
| Yi Sang · Group President, Asia Pacific | 29 May 2026 | Open-market sale | −800 | $82.66 | $66.13K |
|---|
| Noor Jehanzeb · See remarks below. | 1 Apr 2026 | Option exercise | +6.6K | — | — |
|---|
| Noor Jehanzeb · See remarks below. | 1 Apr 2026 | Shares withheld for tax | −1.7K | $90.67 | $152.1K |
|---|
| Winkler Lori · SVP and CHRO | 12 Mar 2026 | Open-market sale | −2.6K | $94.66 | $250.8K |
|---|
| VAN ZUILEN WILFRED · Group Pres, EMEA | 6 Mar 2026 | Option exercise | +2.2K | — | — |
|---|
| VAN ZUILEN WILFRED · Group Pres, EMEA | 6 Mar 2026 | Shares withheld for tax | −562 | $92.54 | $52.01K |
|---|
| VAN ZUILEN WILFRED · Group Pres, EMEA | 6 Mar 2026 | Shares withheld for tax | −1.3K | $92.54 | $116.6K |
|---|
| VAN ZUILEN WILFRED · Group Pres, EMEA | 6 Mar 2026 | Option exercise | +4.8K | — | — |
|---|
| Winkler Lori · SVP and CHRO | 6 Mar 2026 | Option exercise | +1.7K | — | — |
|---|
| Winkler Lori · SVP and CHRO | 6 Mar 2026 | Shares withheld for tax | −629 | $92.54 | $58.21K |
|---|
| Winkler Lori · SVP and CHRO | 6 Mar 2026 | Shares withheld for tax | −1.5K | $92.54 | $143.3K |
|---|
| Winkler Lori · SVP and CHRO | 6 Mar 2026 | Option exercise | +3.9K | — | — |
|---|
| Tornos Ivan · Chairman, President and CEO · Director | 6 Mar 2026 | Shares withheld for tax | −3.0K | $92.54 | $278.4K |
|---|
| Tornos Ivan · Chairman, President and CEO · Director | 6 Mar 2026 | Option exercise | +24.4K | — | — |
|---|
| Tornos Ivan · Chairman, President and CEO · Director | 6 Mar 2026 | Shares withheld for tax | −13.5K | $92.54 | $1.25M |
|---|
| Tornos Ivan · Chairman, President and CEO · Director | 6 Mar 2026 | Option exercise | +5.4K | — | — |
|---|
Form 4 filings since 16 Nov 2024: purchases and sales, grants, option exercises and shares withheld for tax. Gifts and other transfers are left out.
ZBH in the terminal
Holders over eight quarters by family, every Form 4 and Form 144 back two years, and alerts on insider buying.